Tilray Brands (TLRY) Stock: Buy, Sell, or Hold?

TLRY - Tilray Brands, Inc. Common Stock

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
$3.61
0.04 (1.12%) β–²
5d: -12.59%
30d: -20.13%
90d: -17.58%
WAIT
LOW Confidence
Protect Your TLRY Gains
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 08, 2026 4d
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 29, 2026 at $4.00 · last confirmed Sep 29, 2026

Strength: 6.4/10

Get Alerted When TLRY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TLRY is down 12.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: TLRY is currently trading at $3.61, which is considered oversold relative to its 30-day fair value range of $3.89 to $4.54. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.2) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, TLRY is in a strong uptrend. The price is currently testing key support at $3.54. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: TLRY scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.34 (+103.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $3.89 - $4.54
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 61.9%

Protect Your Profits

Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (35/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 103.4% below Wall St target ($7.34)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 49/100 in the bottom quintile β€” this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $3.89 - $4.54
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $3.54
Resistance Level $4.29
Current Trend Strong Uptrend
Technical data as of Oct 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -9.23
Wall Street Target $7.34 (+103.4%)
Revenue Growth (YoY) 25.5%
Profit Margin -13.3%
PE vs Historical -9.2 vs 201.6 CHEAP
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 03, 2026 7:36 AM ET
Data refreshes hourly during market hours. Next update: 8:36 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David G Hopkinson SELL 33556 shares 2026-04-21

Unlock Insider Activity

See real-time buying/selling by company executives for TLRY.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$208 62 BUY
ZTS
Zoetis Inc
BUY
20 analysts
$96 58 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$108 56 HOLD
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 67 BUY
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 47 HOLD

Advanced TLRY Option Strategies

Professional options setups generated by AI based on today's TLRY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TLRY

TLRY Technical Chart TLRY Price Prediction TLRY Earnings Date Why is TLRY Moving Today? TLRY Investment Advisor TLRY Fair Price Analyzer TLRY Options Advisor TLRY Options Chain TLRY Options Analysis TLRY Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals